Experienced strategic advisory board
The PreComb executive management is supported by a diverse team of high-profile strategic advisors from the biotech/pharma industry as well as from experts in clinical and preclinical research.
All members of the advisory board have Practical Pharma Industry experiences with Roche, Novartis, Schering, Alcon & GSK. Together, they have created more than 200 Jobs in Biotech, Pharma and Research.
Advisors at a Glance
- Successful biotech exit for 589 mio USD
- More than 100 years in discovery, preclinical and clinical research
- >50 patents
- >150 scientific publications in peer-reviewed journals
- Creation of more than 200 jobs
Dominik Escher, PhD
Dominik Escher is a co-founder and Executive Chairman of CDR-Life AG and a founding partner of Puros Bioventures. He is also president of the Swiss Biotech Association. Previously, he was a founder and CEO of ESBATech AG, which was acquired in 2009 by Alcon (Novartis) for USD 589 million. As a biotech entrepreneur, he raised USD 89 million for ESBATech to develop novel antibody fragments from discovery to maturity, delivering multiple clinically successful products (e.g. Brolucizumab). Dominik obtained his Ph.D. in Molecular Biology from the University of Zurich and also holds a Masters Degree in Education with specialization in Management and Organization from the ETH of Zurich.
Andrew Thomas, PhD
Andrew Thomas is a managing partner of Helvetica Capital and a founder of the IPSO Group. Previously, he was a founding Executive Board member of the Swiss Industry Science Fund (SISF) and Global Head of Medicinal Chemistry at Roche where he was responsible for development of small molecule drugs in different therapeutic areas including oncology. Andrew holds a PhD in Chemistry from the University of St. Andrews.
Patrick Griss, PhD
Patrick Griss is co-founder and Executive Partner of Zühlke Ventures, the early-stage investment arm of the Zühlke Group. He is an active investor and board member in several technology companies and an expert for digital strategies and business models. Patrick holds a PhD in Microsystem Technology from the KTH Royal Institute of Technology, Stockholm.